D.E. Shaw & Co
AGN

D.E. Shaw & Co’s Allergan plc AGN Stock Holding History

D.E. Shaw & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-86,100
Closed -$16.5M – 4436
2019
Q4 		$16.5M Hold
86,100
– – 0.02% 916
2019
Q3 		$14.5M Sell
86,100
-47,000
-35% -$7.66M 0.02% 946
2019
Q2 		$22.3M Buy
133,100
+40,000
+43% +$5.54M 0.03% 694
2019
Q1 		$13.6M Sell
93,100
-2,700
-3% -$391K 0.02% 919
2018
Q4 		$12.8M Sell
95,800
-60,500
-39% -$9.92M 0.02% 935
2018
Q3 		$29.8M Buy
156,300
+64,700
+71% +$11.9M 0.04% 596
2018
Q2 		$15.3M Buy
91,600
+51,800
+130% +$8.32M 0.02% 862
2018
Q1 		$6.7M Sell
39,800
-86,500
-68% -$14.5M 0.01% 1229
2017
Q4 		$20.7M Buy
126,300
+15,100
+14% +$2.71M 0.03% 663
2017
Q3 		$22.8M Sell
111,200
-90,000
-45% -$20.9M 0.04% 559
2017
Q2 		$48.9M Sell
201,200
-125,700
-38% -$29.5M 0.08% 294
2017
Q1 		$78.1M Buy
326,900
+20,300
+7% +$4.73M 0.14% 171
2016
Q4 		$64.4M Buy
306,600
+19,600
+7% +$4.06M 0.11% 220
2016
Q3 		$66.1M Buy
287,000
+141,800
+98% +$34.7M 0.12% 207
2016
Q2 		$33.6M Buy
145,200
+42,000
+41% +$9.68M 0.06% 375
2016
Q1 		$27.7M Sell
103,200
-98,336
-49% -$28.1M 0.05% 428
2015
Q4 		$63M Buy
201,536
+30,400
+18% +$9.05M 0.09% 251
2015
Q3 		$46.5M Buy
171,136
+17,100
+11% +$5.25M 0.07% 334
2015
Q2 		$46.7M Sell
154,036
-1,400
-0.9% -$418K 0.07% 336
2015
Q1 		$46.3M Buy
155,436
+48,536
+45% +$13.8M 0.07% 327
2014
Q4 		$27.5M Sell
106,900
-115,700
-52% -$28.9M 0.04% 564
2014
Q3 		$53.7M Sell
222,600
-30,800
-12% -$6.89M 0.07% 330
2014
Q2 		$56.5M Buy
253,400
+36,500
+17% +$7.56M 0.08% 297
2014
Q1 		$44.6M Buy
216,900
+3,500
+2% +$693K 0.06% 339
2013
Q4 		$35.9M Buy
213,400
+24,600
+13% +$3.85M 0.05% 424
2013
Q3 		$27.2M Buy
188,800
+88,100
+87% +$11.7M 0.04% 458
2013
Q2 		$12.7M Buy
+100,700
New +$11.4M 0.02% 741

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

D.E. Shaw & Co's AGN Position: Q2 2020 in Review

D.E. Shaw & Co sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 461,899 shares — an estimated $81.8M sold.

D.E. Shaw & Co first reported a position in AGN in Q3 2013 and held it in 27 quarters. The position peaked at $614M in Q1 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • D.E. Shaw & Co reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • D.E. Shaw & Co sold 461,899 Allergan plc shares in Q2 2020, an estimated $81.8M.
  • D.E. Shaw & Co first reported a position in Allergan plc in Q3 2013 and held it in 27 quarters.
  • D.E. Shaw & Co's Allergan plc position peaked at $614M in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on D.E. Shaw & Co's 13F filing for Q2 2020, filed 14 Aug 2020.